« Sinochem enters Permian Basin shale via $1.7B agreement with Pioneer Natural Resources; 40% ownership plus funding for Pioneer | Main | 2013 SAE International High Octane Fuels Symposium: the potential for high octane fuels (Part 1) »
Novozymes acquiring industrial enzyme business from Canadian Iogen Corporation
31 January 2013
Novozymes is acquiring Iogen Bio-Products, the industrial enzyme business of Ottawa-based Iogen Corporation for C$67.5 million (US$67.4 million) and potential earn-out payments of up to C$12.5 million. The deal provides Novozymes with all commercial rights to Iogen Bio-Products’ existing product portfolio, pipeline, facilities and know-how. Novozymes acquires all of Iogen Corporation’s industrial enzyme business. The acquisition does not include the purchase of assets that relate to Iogen Corporation’s bioenergy process technologies.
Iogen Bio-Products, which entered the industrial enzyme industry in 1991, produces and sells enzymes for the pulp & paper, textile, grain-processing and animal feed industries. The company has close to 70 employees and sells more than 20 products globally.
The acquisition is expected to have a positive impact on Novozymes’ sales growth in 2013 of around 0.5 percentage point depending on when the acquisition is closed. The acquisition is expected to have a slightly negative impact on EBIT and EBIT margin in 2013, but outlook for EBIT growth and EBIT margin remains unchanged.
The outlook for ROIC for 2013 is being changed from ~20% to 19-20% as a result of the additional capital invested. Novozymes' outlook for free cash flow excludes acquisitions and remains unchanged for 2013. Outlook assumes rates for the company’s key currencies remain at the closing rates on January 18 for the rest of 2013.
Closing of the acquisition is anticipated late February 2013, awaiting finalization of corporate formalities.
TrackBack URL for this entry:
Listed below are links to weblogs that reference Novozymes acquiring industrial enzyme business from Canadian Iogen Corporation: